Report Detail

Request for Sample of this report

Service & Software Global Third Party Clinical Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4569131
    • |
  • 08 December, 2023
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Third Party Clinical Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Third-party clinical testing refers to clinical testing or pathological diagnosis and other services provided by an independent third-party institution with legal personality, independent of medical institutions.These organizations often include third-party medical testing organizations (also known as Independent Clinical Laboratory or ICL). They can provide a variety of clinical testing and pathological diagnostic services, including but not limited to hematology, immunology, biochemistry, microbiology, genomics and pathology.The emergence of these institutions can effectively improve the efficiency and quality of medical diagnosis, while also reducing medical costs and reducing medical burden.
The driving forces for the development of third-party clinical testing mainly include the following aspects:
Social development and the improvement of people's health awareness: With the development of society and the improvement of people's living standards, people's demand for medical services continues to increase, and their requirements for health and safety are also constantly increasing. This makes medical testing and diagnosis more and more important, thus promoting the development of third-party clinical testing.
Continuous advancement of technology and equipment: With the continuous advancement of medical technology and equipment, the accuracy and reliability of clinical testing have been greatly improved. This also enables third-party clinical testing institutions to better provide high-quality and efficient testing services to medical institutions.
Support from policies and regulations: In order to improve the quality and efficiency of medical services, governments and relevant institutions in various countries are actively promoting the development of third-party clinical testing. The support of these policies and regulations provides favorable conditions for the development of third-party clinical testing.
Needs of hospitals and doctors: Hospitals and doctors also need the support of third-party clinical testing agencies. Due to limited medical resources, hospitals and doctors often need to obtain more professional testing services through third-party clinical testing institutions to better provide treatment services to patients.
Increasing market competition: Competition in the third-party clinical testing market is also increasing. More and more companies are joining this field. In order to gain more market share, they need to continuously improve their technology and service levels, thus promoting the development of third-party clinical testing.
The Global Info Research report includes an overview of the development of the Third Party Clinical Testing industry chain, the market status of Personal (Biochemical Tests, Immunity Tests), Enterprise (Biochemical Tests, Immunity Tests), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Third Party Clinical Testing.
Regionally, the report analyzes the Third Party Clinical Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Third Party Clinical Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Third Party Clinical Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Third Party Clinical Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biochemical Tests, Immunity Tests).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Third Party Clinical Testing market.
Regional Analysis: The report involves examining the Third Party Clinical Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Third Party Clinical Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Third Party Clinical Testing:
Company Analysis: Report covers individual Third Party Clinical Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Third Party Clinical Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Personal, Enterprise).
Technology Analysis: Report covers specific technologies relevant to Third Party Clinical Testing. It assesses the current state, advancements, and potential future developments in Third Party Clinical Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Third Party Clinical Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Third Party Clinical Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Biochemical Tests
Immunity Tests
Routine Blood Tests
Others
Market segment by Application
Personal
Enterprise
Market segment by players, this report covers
Labcorp
IQVIA
PAREXEL International Corporation
ICON Plc
Charles River Laboratories
Syneos Health
PPD (Pharmaceutical Product Development)
Medpace
WuXi AppTec
Kingmed
Dian Diagnostics
Adicon Clinical Laboratories
Kindstar
DaAn Gene
Berry Genomics
Frontage Holdings
Centre Testing International
Shanghai Labway Clinical Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Third Party Clinical Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Third Party Clinical Testing, with revenue, gross margin and global market share of Third Party Clinical Testing from 2018 to 2023.
Chapter 3, the Third Party Clinical Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Third Party Clinical Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Third Party Clinical Testing.
Chapter 13, to describe Third Party Clinical Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Third Party Clinical Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Third Party Clinical Testing by Type
    • 1.3.1 Overview: Global Third Party Clinical Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Third Party Clinical Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Biochemical Tests
    • 1.3.4 Immunity Tests
    • 1.3.5 Routine Blood Tests
    • 1.3.6 Others
  • 1.4 Global Third Party Clinical Testing Market by Application
    • 1.4.1 Overview: Global Third Party Clinical Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Personal
    • 1.4.3 Enterprise
  • 1.5 Global Third Party Clinical Testing Market Size & Forecast
  • 1.6 Global Third Party Clinical Testing Market Size and Forecast by Region
    • 1.6.1 Global Third Party Clinical Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Third Party Clinical Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Third Party Clinical Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Third Party Clinical Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Third Party Clinical Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Third Party Clinical Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Third Party Clinical Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Labcorp
    • 2.1.1 Labcorp Details
    • 2.1.2 Labcorp Major Business
    • 2.1.3 Labcorp Third Party Clinical Testing Product and Solutions
    • 2.1.4 Labcorp Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Labcorp Recent Developments and Future Plans
  • 2.2 IQVIA
    • 2.2.1 IQVIA Details
    • 2.2.2 IQVIA Major Business
    • 2.2.3 IQVIA Third Party Clinical Testing Product and Solutions
    • 2.2.4 IQVIA Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 IQVIA Recent Developments and Future Plans
  • 2.3 PAREXEL International Corporation
    • 2.3.1 PAREXEL International Corporation Details
    • 2.3.2 PAREXEL International Corporation Major Business
    • 2.3.3 PAREXEL International Corporation Third Party Clinical Testing Product and Solutions
    • 2.3.4 PAREXEL International Corporation Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 PAREXEL International Corporation Recent Developments and Future Plans
  • 2.4 ICON Plc
    • 2.4.1 ICON Plc Details
    • 2.4.2 ICON Plc Major Business
    • 2.4.3 ICON Plc Third Party Clinical Testing Product and Solutions
    • 2.4.4 ICON Plc Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 ICON Plc Recent Developments and Future Plans
  • 2.5 Charles River Laboratories
    • 2.5.1 Charles River Laboratories Details
    • 2.5.2 Charles River Laboratories Major Business
    • 2.5.3 Charles River Laboratories Third Party Clinical Testing Product and Solutions
    • 2.5.4 Charles River Laboratories Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.6 Syneos Health
    • 2.6.1 Syneos Health Details
    • 2.6.2 Syneos Health Major Business
    • 2.6.3 Syneos Health Third Party Clinical Testing Product and Solutions
    • 2.6.4 Syneos Health Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Syneos Health Recent Developments and Future Plans
  • 2.7 PPD (Pharmaceutical Product Development)
    • 2.7.1 PPD (Pharmaceutical Product Development) Details
    • 2.7.2 PPD (Pharmaceutical Product Development) Major Business
    • 2.7.3 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product and Solutions
    • 2.7.4 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 PPD (Pharmaceutical Product Development) Recent Developments and Future Plans
  • 2.8 Medpace
    • 2.8.1 Medpace Details
    • 2.8.2 Medpace Major Business
    • 2.8.3 Medpace Third Party Clinical Testing Product and Solutions
    • 2.8.4 Medpace Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Medpace Recent Developments and Future Plans
  • 2.9 WuXi AppTec
    • 2.9.1 WuXi AppTec Details
    • 2.9.2 WuXi AppTec Major Business
    • 2.9.3 WuXi AppTec Third Party Clinical Testing Product and Solutions
    • 2.9.4 WuXi AppTec Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 WuXi AppTec Recent Developments and Future Plans
  • 2.10 Kingmed
    • 2.10.1 Kingmed Details
    • 2.10.2 Kingmed Major Business
    • 2.10.3 Kingmed Third Party Clinical Testing Product and Solutions
    • 2.10.4 Kingmed Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Kingmed Recent Developments and Future Plans
  • 2.11 Dian Diagnostics
    • 2.11.1 Dian Diagnostics Details
    • 2.11.2 Dian Diagnostics Major Business
    • 2.11.3 Dian Diagnostics Third Party Clinical Testing Product and Solutions
    • 2.11.4 Dian Diagnostics Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Dian Diagnostics Recent Developments and Future Plans
  • 2.12 Adicon Clinical Laboratories
    • 2.12.1 Adicon Clinical Laboratories Details
    • 2.12.2 Adicon Clinical Laboratories Major Business
    • 2.12.3 Adicon Clinical Laboratories Third Party Clinical Testing Product and Solutions
    • 2.12.4 Adicon Clinical Laboratories Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Adicon Clinical Laboratories Recent Developments and Future Plans
  • 2.13 Kindstar
    • 2.13.1 Kindstar Details
    • 2.13.2 Kindstar Major Business
    • 2.13.3 Kindstar Third Party Clinical Testing Product and Solutions
    • 2.13.4 Kindstar Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Kindstar Recent Developments and Future Plans
  • 2.14 DaAn Gene
    • 2.14.1 DaAn Gene Details
    • 2.14.2 DaAn Gene Major Business
    • 2.14.3 DaAn Gene Third Party Clinical Testing Product and Solutions
    • 2.14.4 DaAn Gene Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 DaAn Gene Recent Developments and Future Plans
  • 2.15 Berry Genomics
    • 2.15.1 Berry Genomics Details
    • 2.15.2 Berry Genomics Major Business
    • 2.15.3 Berry Genomics Third Party Clinical Testing Product and Solutions
    • 2.15.4 Berry Genomics Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Berry Genomics Recent Developments and Future Plans
  • 2.16 Frontage Holdings
    • 2.16.1 Frontage Holdings Details
    • 2.16.2 Frontage Holdings Major Business
    • 2.16.3 Frontage Holdings Third Party Clinical Testing Product and Solutions
    • 2.16.4 Frontage Holdings Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Frontage Holdings Recent Developments and Future Plans
  • 2.17 Centre Testing International
    • 2.17.1 Centre Testing International Details
    • 2.17.2 Centre Testing International Major Business
    • 2.17.3 Centre Testing International Third Party Clinical Testing Product and Solutions
    • 2.17.4 Centre Testing International Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Centre Testing International Recent Developments and Future Plans
  • 2.18 Shanghai Labway Clinical Laboratory
    • 2.18.1 Shanghai Labway Clinical Laboratory Details
    • 2.18.2 Shanghai Labway Clinical Laboratory Major Business
    • 2.18.3 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product and Solutions
    • 2.18.4 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Shanghai Labway Clinical Laboratory Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Third Party Clinical Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Third Party Clinical Testing by Company Revenue
    • 3.2.2 Top 3 Third Party Clinical Testing Players Market Share in 2022
    • 3.2.3 Top 6 Third Party Clinical Testing Players Market Share in 2022
  • 3.3 Third Party Clinical Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Third Party Clinical Testing Market: Region Footprint
    • 3.3.2 Third Party Clinical Testing Market: Company Product Type Footprint
    • 3.3.3 Third Party Clinical Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Third Party Clinical Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Third Party Clinical Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Third Party Clinical Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Third Party Clinical Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Third Party Clinical Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Third Party Clinical Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Third Party Clinical Testing Market Size by Country
    • 6.3.1 North America Third Party Clinical Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Third Party Clinical Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Third Party Clinical Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Third Party Clinical Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Third Party Clinical Testing Market Size by Country
    • 7.3.1 Europe Third Party Clinical Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Third Party Clinical Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Third Party Clinical Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Third Party Clinical Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Third Party Clinical Testing Market Size by Region
    • 8.3.1 Asia-Pacific Third Party Clinical Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Third Party Clinical Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Third Party Clinical Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Third Party Clinical Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Third Party Clinical Testing Market Size by Country
    • 9.3.1 South America Third Party Clinical Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Third Party Clinical Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Third Party Clinical Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Third Party Clinical Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Third Party Clinical Testing Market Size by Country
    • 10.3.1 Middle East & Africa Third Party Clinical Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Third Party Clinical Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Third Party Clinical Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Third Party Clinical Testing Market Drivers
  • 11.2 Third Party Clinical Testing Market Restraints
  • 11.3 Third Party Clinical Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Third Party Clinical Testing Industry Chain
  • 12.2 Third Party Clinical Testing Upstream Analysis
  • 12.3 Third Party Clinical Testing Midstream Analysis
  • 12.4 Third Party Clinical Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Third Party Clinical Testing. Industry analysis & Market Report on Third Party Clinical Testing is a syndicated market report, published as Global Third Party Clinical Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Third Party Clinical Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo